The global cholecystectomy devices market size is expected to reach USD 85.37 million by 2032, according to a new study by Polaris Market Research. The report “Cholecystectomy Devices Market Share, Size, Trends, Industry Analysis Report, By Device (Conventional Cholecystectomy Devices and Robotic-Assigned Cholecystectomy Surgery Devices); By Surgery Type; By Indication; By End-Use; By Region; Segment Forecast, 2023-2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The widespread availability of advanced devices that offer several advantages over traditional instruments, including improved safety, reduced post-operative pain, ad shorter procedure times, along with a surging number of mergers and acquisitions by key market players, are driving the market growth worldwide. Additionally, many players are heavily investing in R&D to introduce cutting-edge products and new product innovations to meet the rising demand from the healthcare industry, which will further create huge growth opportunities for the market.
For instance, in September 2022, Olympus Corporation unveiled their new VIESRA ELITE III, a new surgical visualization platform addressing the needs of healthcare professionals. It offers several imaging functions supported in a single system, enabling minimally invasive therapies.
Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below: https://www.polarismarketresearch.com/industry-analysis/cholecystectomy-devices-market/request-for-sample
The development of several types of advanced laparoscopic instruments and devices with improved features such as better visualization, increased precision, and greater safety has emerged as a key trend in the market. Apart from this, with the advancements in technology and techniques, more cholecystectomies are being performed on an outpatient basis, which has led to the development of devices specifically designed for outpatient procedures.
In the last few years, robotic-assisted surgery has been a drastically rising field, and the use of robotics in cholecystectomy procedures is gaining momentum as it provides numerous benefits such as increased precision, faster recovery times, and many others, which fuels its adoption among a large number of surgeons globally.
Cholecystectomy Devices Market Report Highlights
Polaris Market Research has segmented the cholecystectomy devices market report based on device, surgery type, indication, end-use, and region:
Cholecystectomy Devices, Device Outlook (Revenue - USD Million, 2019 - 2032)
Cholecystectomy Devices, Surgery Type Outlook (Revenue - USD Million, 2019 - 2032)
Cholecystectomy Devices, Indication Outlook (Revenue - USD Million, 2019 - 2032)
Cholecystectomy Devices, End-Use Outlook (Revenue - USD Million, 2019 - 2032)
Cholecystectomy Devices, Regional Outlook (Revenue - USD Million, 2019 - 2032)
Report Attributes |
Details |
Market size value in 2023 |
USD 47.22 million |
Revenue forecast in 2032 |
USD 85.37 million |
CAGR |
6.8% from 2023 – 2032 |
Base year |
2022 |
Historical data |
2019– 2021 |
Forecast period |
2023– 2032 |
Quantitative units |
Revenue in USD million/billion and CAGR from 2022 to 2030 |
Segments covered |
By Device, By Surgery Type, By Indication, By End-Use, By Region |
Regional scope |
North America, Europe, Asia Pacific, Latin America; Middle East & Africa |
Key companies |
Surgical Holding, B. Braun SE, Surtex Instruments Ltd., Millennium Surgical, Stryker Corporation, Medtronic, Intuitive Surgical, GerMedUSA, Sklar Surgical Instruments, Olympus, Mindray Medical International Ltd., Smith & Nephew PLC, AMNOTEC International Medical, Strauss Surgical, EndoMed Systems GmbH, Becton, Dickson and Company, and CONMED Corporation. |
For Specific Research Requirements |